Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 5Terminated 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Renal Cell 24Kidney Neoplasms 10Neoplasms 9Carcinoma 6Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoma, Non-Small-Cell Lung 4Recurrence 3Neoplasm Metastasis 3Melanoma 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Lung Neoplasms 2Kidney Diseases 2Glioblastoma 2Carcinoma, Adenoid Cystic 2Breast Neoplasms 2Advanced Solid Tumors 2cT2a N0NxM0 Renal Tumor 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumors 1Solid Tumors 1Solid Malignancies 1Skin Neoplasms 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1Prostatic Neoplasms 1

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32Bevacizumab 28lenvatinib 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × Axitinib × Clear all
NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Pfizer

Phase 1 Completed
22 enrolled 25 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms

NCT01334112 2019-12-12

AXITINIB

University Health Network, Toronto

Phase 2 Completed
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01210495 2019-01-09

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Pfizer

Phase 2 Completed
224 enrolled 35 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01352728 2018-06-20

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Chinese University of Hong Kong

Phase 2 Completed
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01273662 2017-02-09

Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 2 Completed
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡